Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-5-15
pubmed:abstractText
Development of potential cancer chemopreventive drugs involves the systematic evaluation of these drugs in preliminary Phase I and II studies in human beings to identify the optimal drug dose, drug toxicity, and surrogate end point biomarker modulation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1055-9965
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-53
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11352853-Adult, pubmed-meshheading:11352853-Aged, pubmed-meshheading:11352853-Analysis of Variance, pubmed-meshheading:11352853-Aspirin, pubmed-meshheading:11352853-Biopsy, Needle, pubmed-meshheading:11352853-Carcinoma, pubmed-meshheading:11352853-Colorectal Neoplasms, pubmed-meshheading:11352853-Dinoprostone, pubmed-meshheading:11352853-Dose-Response Relationship, Drug, pubmed-meshheading:11352853-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:11352853-Female, pubmed-meshheading:11352853-Humans, pubmed-meshheading:11352853-Intestinal Mucosa, pubmed-meshheading:11352853-Male, pubmed-meshheading:11352853-Middle Aged, pubmed-meshheading:11352853-Proportional Hazards Models, pubmed-meshheading:11352853-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:11352853-Reference Values, pubmed-meshheading:11352853-Risk Assessment, pubmed-meshheading:11352853-Sensitivity and Specificity, pubmed-meshheading:11352853-Tumor Markers, Biological
pubmed:year
2001
pubmed:articleTitle
Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
pubmed:affiliation
Department of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University and Medical Service, James H. Quillen Veterans Affairs Medical Center, Johnson City, Tennessee 37604, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Controlled Clinical Trial, Research Support, Non-U.S. Gov't